Literature DB >> 2226536

Transport, interactions and retention of plasma proteins in the intima: the barrier function of the internal elastic lamina.

E B Smith1.   

Abstract

This paper presents a brief overview of our current understanding of the relation between plasma macromolecules and atherogenesis. Plasma proteins enter normal intima by vesicular transport across normal endothelium, and convective transport within the intima; accumulation depends mainly on molecular size and the molecular sieve properties of the internal elastic lamina. Within the intima the proteins may be modified; particularly striking changes occur in high density lipoprotein (HDL) and in fibrinogen. Fibrinogen appears to be converted to fibrin which is then lysed, providing a continuing source of fibrin degradation products (FDP). Fibrin also seems to be associated with a tightly bound, plasmin-releasable apo-B-containing lipoprotein; work in progress suggests that much of this fraction is accounted for by lipoprotein(a).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2226536     DOI: 10.1093/eurheartj/11.suppl_e.72

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  16 in total

Review 1.  Receptor-independent fluid-phase pinocytosis mechanisms for induction of foam cell formation with native low-density lipoprotein particles.

Authors:  Howard S Kruth
Journal:  Curr Opin Lipidol       Date:  2011-10       Impact factor: 4.776

2.  Effects of phospholipase A(2) and its products on structural stability of human LDL: relevance to formation of LDL-derived lipid droplets.

Authors:  Shobini Jayaraman; Donald L Gantz; Olga Gursky
Journal:  J Lipid Res       Date:  2011-01-10       Impact factor: 5.922

3.  Murine bone marrow-derived macrophages differentiated with GM-CSF become foam cells by PI3Kγ-dependent fluid-phase pinocytosis of native LDL.

Authors:  Joshua J Anzinger; Janet Chang; Qing Xu; Manoj K Barthwal; Thomas Bohnacker; Matthias P Wymann; Howard S Kruth
Journal:  J Lipid Res       Date:  2011-11-04       Impact factor: 5.922

Review 4.  Acidification of the intimal fluid: the perfect storm for atherogenesis.

Authors:  Katariina Öörni; Kristiina Rajamäki; Su Duy Nguyen; Katariina Lähdesmäki; Riia Plihtari; Miriam Lee-Rueckert; Petri T Kovanen
Journal:  J Lipid Res       Date:  2014-11-25       Impact factor: 5.922

5.  Distribution patterns of apolipoproteins A1, A2, and B in the wall of atherosclerotic vessels.

Authors:  E Vollmer; J Brust; A Roessner; A Bosse; F Burwikel; B Kaesberg; B Harrach; H Robenek; W Böcker
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

6.  Plasma protein insudation as an index of early coronary atherogenesis.

Authors:  Y Zhang; W J Cliff; G I Schoefl; G Higgins
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

7.  Fluorescent pegylated nanoparticles demonstrate fluid-phase pinocytosis by macrophages in mouse atherosclerotic lesions.

Authors:  Chiara Buono; Joshua J Anzinger; Marcelo Amar; Howard S Kruth
Journal:  J Clin Invest       Date:  2009-04-13       Impact factor: 14.808

Review 8.  Atherosclerosis: integration of its pathogenesis as a self-perpetuating propagating inflammation: a review.

Authors:  Robin N Poston
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-05-15

9.  Chymase in exocytosed rat mast cell granules effectively proteolyzes apolipoprotein AI-containing lipoproteins, so reducing the cholesterol efflux-inducing ability of serum and aortic intimal fluid.

Authors:  L Lindstedt; M Lee; G R Castro; J C Fruchart; P T Kovanen
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

10.  Enzymatically Modified Low-Density Lipoprotein Promotes Foam Cell Formation in Smooth Muscle Cells via Macropinocytosis and Enhances Receptor-Mediated Uptake of Oxidized Low-Density Lipoprotein.

Authors:  Bijoy Chellan; Catherine A Reardon; Godfrey S Getz; Marion A Hofmann Bowman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-04-14       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.